Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE

Vanguard Capital Management LLC reported a 5.13% stake in Ultragenyx Pharmaceutical Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Jul 31, 2026

Vanguard Capital Management LLC reported a 5.13% stake in Ultragenyx Pharmaceutical Inc., 5,058,419 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).

Stake
5.13%
Shares
5,058,419
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Vanguard Capital Management5.13%5,058,419

Source

View original at SEC

Related